Pharma:

More documents

Recommendations

Info

Why is MLR Pushing Back? Company Level Fines Exclusions Sale of Company Individual Level Fines Exclusions Criminal Penalties Personal Shame Loss of Licenses
Good Promotion Practices
Page 1 and 2:
Darshan Kulkarni, Pharm.D, MS, Esq.
Page 3 and 4: Pharm.D JD MS in QA/RA
Page 5 and 6: Compliance Legal Regulatory
Page 7 and 8: What are 3 elements you want in you
Page 9 and 10: What is this presentation NOT about
Page 11 and 12: What is this presentation NOT about
Page 13 and 14: Participating in Social Media Pros
Page 15 and 16: Pros • It is instantaneous.
Page 17 and 18: Cons • Once something is out ther
Page 19 and 20: Cons • If I don’t know about it
Page 21 and 22: Cons • Inadequate Guidance
Page 23 and 24: Code of Conduct Sexual Harassment P
Page 25 and 26: • DMCA Concerns •Have take down
Page 27 and 28: Decide which sites you will “adop
Page 29 and 30: You are the brand manager for a dru
Page 33: Social Media Don'ts Using parent/su
Page 37 and 38: Promotions Recap
Page 39 and 40: Types of DTC Ads • Help Seeking A
Page 41 and 42: Types of DTC Ads Product Claim Ad
Page 43 and 44: Current State • Distinguish betwe
Page 45 and 46: Current State • Astra Zeneca: Twi
Page 47 and 48: • The "Invisibility Rule" does no
Page 49 and 50: Enforcement Actions Trending
Page 51 and 52: What Should You Do? You are the bra
Page 53: Enforcement Actions
Page 58 and 59: Good Pharma Social Media Promotion
Page 60 and 61: Good Pharma Social Media Promotion
Page 62 and 63: Monitor Use Third Parties to evalua
Page 64 and 65: Your SM Policy What are 3 elements
Page 66 and 67: Social Media Guidances FDA is expec
Page 69 and 70: Future of Social Media • DDMAC is
Page 71 and 72: ... but we don’t have all the SM
Page 73 and 74: Questions? @FDALawyers Join us to c
show all

Pharma:

Create successful ePaper yourself

Delete template?

Save as template?